Look Up > Drugs > Pentaerythritol Tetranitrate
Pentaerythritol Tetranitrate
Pronunciation
U.S. Brand Names
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Dietary Considerations
Cardiovascular Considerations
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms

Pronunciation
(pen ta er ITH ri tole te tra NYE trate)

U.S. Brand Names
Duotrate®; Peritrate®; Peritrate® SA

Generic Available

Yes


Synonyms
PETN

Pharmacological Index

Vasodilator


Use

Possibly effective for the prophylactic long-term management of angina pectoris. Note: Not indicated to abort acute anginal episodes.


Pregnancy Risk Factor

C


Contraindications

Hypersensitivity to pentaerythritol tetranitrate or other nitrates; severe anemia; angle-closure glaucoma; postural hypotension; cerebral hemorrhage; head trauma


Warnings/Precautions

Use with caution in patients with hypotension, hypovolemia, or increased intracranial pressure.


Adverse Reactions

>10%:

Cardiovascular: Flushing, postural hypotension

Central nervous system: Headache, lightheadedness, dizziness

Neuromuscular & skeletal: Weakness

1% to 10%: Dermatologic: Drug rash, exfoliative dermatitis

<1% (Limited to important or life-threatening symptoms): Nausea, vomiting, methemoglobinemia (overdose)


Drug Interactions

Alcohol (increased hypotension)

Aspirin (increases serum nitrate concentration)

Calcium channel blockers (increases hypotension)

Heparin's anticoagulant effect may be antagonized

Sildenafil: May cause severe hypotension; use is contraindicated.


Mechanism of Action

Stimulation of intracellular cyclic-GMP results in vascular smooth muscle relaxation of both arterial and venous vasculature. Increased venous pooling decreases left ventricular pressure (preload) and arterial dilatation decreases arterial resistance (afterload). Therefore, this reduces cardiac oxygen demand by decreasing left ventricular pressure and systemic vascular resistance by dilating arteries. Additionally, coronary artery dilation improves collateral flow to ischemic regions; esophageal smooth muscle is relaxed via the same mechanism.


Pharmacodynamics/Kinetics

Onset of hemodynamic effect: Oral: Within 20-60 minutes

Duration: 4-5 hours, or up to 12 hours with the sustained release formulations

Serum half-life: 10 minutes


Usual Dosage

Adults: Oral: 10-20 mg 4 times/day up to 40 mg 4 times/day before or after meals and at bedtime; sustained release preparation 80 mg twice daily; use lowest recommended doses in elderly initially; titrations up to 240 mg/day are tolerated, however, headache may occur with increasing doses (reduce dose for a few days; if headache returns or is persistent, an analgesic can be used to treat symptoms)


Dietary Considerations

Should be administered with glass of water on an empty stomach


Cardiovascular Considerations

Concomitant use of sildenafil (Viagra®) may precipitate acute hypotension, myocardial infarction, or death. Nitrates used in right ventricular infarction may induce acute hypotension. Nitrate use in severe pericardial effusion may reduce cardiac filling pressure and precipitate cardiac tamponade.


Mental Health: Effects on Mental Status

May cause drowsiness


Mental Health: Effects on Psychiatric Treatment

None reported


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

No effects or complications reported


Patient Information

Keep tablets in original tightly closed container; do not chew or crush sustained release product


Nursing Implications

Do not crush sustained release drug product

Monitor blood pressure reduction for maximal effect and orthostatic hypotension


Dosage Forms

Capsule: sustained release: 15 mg, 30 mg

Tablet: 10 mg, 20 mg, 40 mg

Sustained release: 80 mg


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved